Blood-based screening test for early detection of gastric cancer using biomarker analysis. Designed for non-invasive risk stratification and identification of high-risk patients requiring endoscopic evaluation. Supports clinical decision-making in gastric cancer prevention and early diagnosis.
Manufactured by
HymonBio Co., Ltd.
Suzhou, Jiangsu, China
HymonBio Co., Ltd. was established in 2015, with co-founder from the Chinese Academy of Sciences. The company focuses on the development, production, and sale of precision-medicine and point-of-care (POCT) related products. Since its establishment in Taicang BIOBAY, HymonBio has applied for 36 patents and obtained 16 authorized patents; 11 products have obtained Chinese medical device certificates; 59 products have obtained CE certificates; 1 product has obtained an FDA certificate and passed the ISO13485 system certificate. The company has won awards such as high-tech enterprises, private technology enterprises in Jiangsu Province, enterprises supported by the Double Innovation Plan of Jiangsu Province, and Suzhou Female Innovation and Entrepreneurship Leading Talent Enterprises. Most recently, HymonBio has completed the first round of financing, which is also the first overseas investment project of PerkinElmer Ventures, a leading company in the IVD industry, in China.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Singlera GENOMICS (SHANGHAI) Ltd.
China · 9 relevant products
Anhui Huibang Biological Engineering Co., Ltd.
China · 1 relevant product
ACON Laboratories, Inc.
United States · 1 relevant product
58 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →12 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 99 closest product alternatives
Singlera GENOMICS (SHANGHAI) Ltd. · China
A DNA methylation-based diagnostic test for early detection and risk assessment of hepatocellular carcinoma. Provides comprehensive screening capabilities for liver cancer malignancies.
Anhui Huibang Biological Engineering Co., Ltd. · China
A serological immunodiagnostic system for combined detection of PGI/II and G17 markers to evaluate gastric mucosa atrophy location and differentiate types of gastric atrophy. It features rapid detection, combined biomarkers, and quantitative analysis, approved for market launch in September 2022.
ACON Laboratories, Inc. · United States
Qualitative screening immunoassay for the detection of cancer markers. Designed for reliable and accessible cancer risk assessment in point-of-care settings.
96 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products